These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33860441)

  • 1. Magnetic Targeting of Human Olfactory Mucosa Stem Cells Following Intranasal Administration: a Novel Approach to Parkinson's Disease Treatment.
    Simorgh S; Bagher Z; Farhadi M; Kamrava SK; Boroujeni ME; Namjoo Z; Hour FQ; Moradi S; Alizadeh R
    Mol Neurobiol; 2021 Aug; 58(8):3835-3847. PubMed ID: 33860441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Olfactory mucosa stem cells delivery via nasal route: a simple way for the treatment of Parkinson disease.
    Simorgh S; Alizadeh R; Shabani R; Karimzadeh F; Seidkhani E; Majidpoor J; Moradi F; Kasbiyan H
    Neurotox Res; 2021 Jun; 39(3):598-608. PubMed ID: 33433781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olfactory mucosa stem cells: An available candidate for the treatment of the Parkinson's disease.
    Simorgh S; Alizadeh R; Eftekharzadeh M; Haramshahi SMA; Milan PB; Doshmanziari M; Ramezanpour F; Gholipourmalekabadi M; Seifi M; Moradi F
    J Cell Physiol; 2019 Dec; 234(12):23763-23773. PubMed ID: 31173364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implantation of human olfactory ecto-mesenchymal stem cells restores locomotion in a rat model of Parkinson's disease.
    Farhadi M; Boroujeni ME; Kamrava SK; Bagher Z; Tehrani AM; Aghajanpour F; Ezi S; Soltani R; Khatmi A; Alizadeh R
    J Chem Neuroanat; 2021 Jul; 114():101961. PubMed ID: 33933574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic targeted delivery of the SPIONs-labeled mesenchymal stem cells derived from human Wharton's jelly in Alzheimer's rat models.
    Hour FQ; Moghadam AJ; Shakeri-Zadeh A; Bakhtiyari M; Shabani R; Mehdizadeh M
    J Control Release; 2020 May; 321():430-441. PubMed ID: 32097673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From Transcriptome to Behavior: Intranasal Injection of Late Passage Human Olfactory Stem Cells Displays Potential in a Rat Model of Parkinson's Disease.
    Alizadeh R; Boroujeni ME; Kamrava SK; Tehrani AM; Bagher Z; Heidari F; Bluyssen HAR; Farhadi M
    ACS Chem Neurosci; 2021 Jun; 12(12):2209-2217. PubMed ID: 34048212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation of human olfactory system-derived stem cells into dopaminergic neuron-like cells: A comparison between olfactory bulb and mucosa as two sources of stem cells.
    Alizadeh R; Ramezanpour F; Mohammadi A; Eftekharzadeh M; Simorgh S; Kazemiha M; Moradi F
    J Cell Biochem; 2019 Dec; 120(12):19712-19720. PubMed ID: 31297865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced Homing Technique of Mesenchymal Stem Cells Using Iron Oxide Nanoparticles by Magnetic Attraction in Olfactory-Injured Mouse Models.
    Yun WS; Choi JS; Ju HM; Kim MH; Choi SJ; Oh ES; Seo YJ; Key J
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29734748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heat shock protein 60 affects behavioral improvement in a rat model of Parkinson's disease grafted with human umbilical cord mesenchymal stem cell-derived dopaminergic-like neurons.
    Zhao C; Li H; Zhao XJ; Liu ZX; Zhou P; Liu Y; Feng MJ
    Neurochem Res; 2016 Jun; 41(6):1238-49. PubMed ID: 26758268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human olfactory stem cells: As a promising source of dopaminergic neuron-like cells for treatment of Parkinson's disease.
    Alizadeh R; Kamrava SK; Bagher Z; Farhadi M; Falah M; Moradi F; Boroujeni ME; Soleimani M; Kamyab A; Komeili A
    Neurosci Lett; 2019 Mar; 696():52-59. PubMed ID: 30552942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal delivery of bone marrow-derived mesenchymal stem cells, macrophages, and microglia to the brain in mouse models of Alzheimer's and Parkinson's disease.
    Danielyan L; Beer-Hammer S; Stolzing A; Schäfer R; Siegel G; Fabian C; Kahle P; Biedermann T; Lourhmati A; Buadze M; Novakovic A; Proksch B; Gleiter CH; Frey WH; Schwab M
    Cell Transplant; 2014; 23 Suppl 1():S123-39. PubMed ID: 25302802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation of human mesenchymal stem cells (MSC) to dopaminergic neurons: A comparison between Wharton's Jelly and olfactory mucosa as sources of MSCs.
    Alizadeh R; Bagher Z; Kamrava SK; Falah M; Ghasemi Hamidabadi H; Eskandarian Boroujeni M; Mohammadi F; Khodaverdi S; Zare-Sadeghi A; Olya A; Komeili A
    J Chem Neuroanat; 2019 Mar; 96():126-133. PubMed ID: 30639339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of intranasal stem cell administration on the nigrostriatal system in a mouse model of Parkinson's disease.
    Salama M; Sobh M; Emam M; Abdalla A; Sabry D; El-Gamal M; Lotfy A; El-Husseiny M; Sobh M; Shalash A; Mohamed WM
    Exp Ther Med; 2017 Mar; 13(3):976-982. PubMed ID: 28450929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human olfactory epithelium-derived stem cells ameliorate histopathological deficits and improve behavioral functions in a rat model of cerebellar ataxia.
    Moghaddam MH; Hatari S; Shahidi AMEJ; Nikpour F; Omran HS; Fathi M; Vakili K; Abdollahifar MA; Tizro M; Eskandari N; Raoofi A; Ebrahimi V; Aliaghaei A
    J Chem Neuroanat; 2022 Mar; 120():102071. PubMed ID: 35051594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo magnetic resonance imaging of iron oxide-labeled, intravenous-injected mesenchymal stem cells in kidneys of rabbits with acute ischemic kidney injury: detection and monitoring at 1.5 T.
    Zhang R; Li J; Xin L; Xie J
    Ren Fail; 2015; 37(8):1363-9. PubMed ID: 26248484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Docosahexaenoic acid promotes dopaminergic differentiation in induced pluripotent stem cells and inhibits teratoma formation in rats with Parkinson-like pathology.
    Chang YL; Chen SJ; Kao CL; Hung SC; Ding DC; Yu CC; Chen YJ; Ku HH; Lin CP; Lee KH; Chen YC; Wang JJ; Hsu CC; Chen LK; Li HY; Chiou SH
    Cell Transplant; 2012; 21(1):313-32. PubMed ID: 21669041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. bFGF promotes the differentiation and effectiveness of human bone marrow mesenchymal stem cells in a rotenone model for Parkinson's disease.
    Xiong N; Yang H; Liu L; Xiong J; Zhang Z; Zhang X; Jia M; Huang J; Zhang Z; Mohamed AA; Lin Z; Wang T
    Environ Toxicol Pharmacol; 2013 Sep; 36(2):411-422. PubMed ID: 23770451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic efficacy of intranasally delivered mesenchymal stem cells in a rat model of Parkinson disease.
    Danielyan L; Schäfer R; von Ameln-Mayerhofer A; Bernhard F; Verleysdonk S; Buadze M; Lourhmati A; Klopfer T; Schaumann F; Schmid B; Koehle C; Proksch B; Weissert R; Reichardt HM; van den Brandt J; Buniatian GH; Schwab M; Gleiter CH; Frey WH
    Rejuvenation Res; 2011 Feb; 14(1):3-16. PubMed ID: 21291297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Olfactory mucosa is a potential source for autologous stem cell therapy for Parkinson's disease.
    Murrell W; Wetzig A; Donnellan M; Féron F; Burne T; Meedeniya A; Kesby J; Bianco J; Perry C; Silburn P; Mackay-Sim A
    Stem Cells; 2008 Aug; 26(8):2183-92. PubMed ID: 18535154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transplantation of neural stem cells co-transfected with Nurr1 and Brn4 for treatment of Parkinsonian rats.
    Tan X; Zhang L; Qin J; Tian M; Zhu H; Dong C; Zhao H; Jin G
    Int J Dev Neurosci; 2013 Feb; 31(1):82-7. PubMed ID: 23085081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.